Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Alimera, Control Delivery Systems develop DME therapy; later add other indications, amend deal

Executive Summary

Ophthalmic pharmaceuticals start-up Alimera Sciences (founded 2003--developing and in-licensing OTC and prescription eye care treatments) and back-of-eye drug delivery firm Control Delivery Systems will collaborate on the development and marketing of a treatment for diabetic macular edema, a condition that can lead to vision loss in diabetic retinopathy patients.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • Includes Royalty or Profit Split Information
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register